Table 1 Comparison of baseline, clinical, and radiological characteristics between patients with and without receiving early BP reduction
Variables | Without early BP lowering treatment (n = 183) | Early BP lowering treatment (n = 212) | P value |
|---|---|---|---|
Demographics | |||
Mean age, year (SD) | 59.99 (12.87) | 59.56 (13.79) | 0.750 |
Sex, male, n(%) | 121 (66.12) | 147 (69.34) | 0.495 |
Medical history | |||
Alcohol consumption, n (%) | 62 (33.88) | 82 (38.68) | 0.212 |
Smoking, n (%) | 79 (43.17) | 106 (50.00) | 0.175 |
History of Hypertension, n (%) | 125 (68.31) | 172 (81.13) | 0.003 |
History of diabetes, n (%) | 25 (13.66) | 35 (16.51) | 0.461 |
Previous ischemic stroke, n (%) | 16 (8.74) | 14 (6.60) | 0.438 |
Previous hemorrhagic stroke, n (%) | 14 (7.65) | 20 (9.43) | 0.510 |
Clinical features | |||
Admission SBP, mmHg (SD) | 181.93 (23.34) | 184.81 (22.74) | 0.216 |
Median admission GCS score (IQR) | 14 (10–15) | 14 (12–15) | 0.532 |
Median admission NIHSS score (IQR) | 10 (6–17) | 11 (5–16) | 0.728 |
Median hematoma volume, ml (IQR) | 11.47 (6.41–22.15) | 11.30 (6.03–20.68) | 0.601 |
Hematoma expansion, n (%) | 31 (16.94) | 41 (19.34) | 0.538 |
Median time from onset to imaging, h (IQR) | 2.12 (1.31–3.25) | 2.00 (1.26–3.60) | 0.526 |
Median time from onset to treatment, h (IQR) | - | 4.03(2.7–5.67) | - |
IVH at baseline CT, n (%) | 63(34.43) | 74 (34.91) | 0.920 |
Deep location, n (%) | 148 (80.87) | 156 (73.58) | 0.102 |
Laboratory values | |||
White blood cell count, 109/L(IQR) | 9.49(7.32–11.40) | 9.97(7.48–12.73) | 0.151 |
Hemoglobin, g/dL(IQR) | 141.0(132.0–152.0) | 143.0(133.0–155.0) | 0.282 |
Platelets,109/L(IQR) | 179.0(143.5–221.0) | 181.0(140.0–216.3) | 0.540 |
Serum creatinine,μmol/L(IQR) | 66.0(56.0–81.0) | 71.0(57.0–86.0) | 0.060 |
Blood glucose level, mmol/L | 6.7(5.6–8.3) | 7.2(5.9–9.2) | 0.032 |